TerrAscend, a Toronto-based vertically integrated marijuana company, reported revenues of 14.6 million Canadian dollars ($10.95 million) for the quarter ended March 31, 2019, with a net loss of CA$11.2 million.
The company did not report revenues for the comparable quarter in 2018. Its net loss for that period was CA$2.35 million.
During the quarter, TerrAscend acquired The Apothecarium, a San Francisco-based retailer, in a deal worth more than $118 million.
TerrAscend trades on the Canadian Securities Exchange under the ticker symbol TER.
More details on the company’s quarterly results can be found here.